EP Edge® Journal Watch: Issue 43 November 2026: VT Ablation, Idiopathic VF, His-Bundle Pacing and Endocarditis

Episode 50

0:00-27:55

EP Edge® Journal Watch 43 | November 2026: VT Ablation, Idiopathic VF, His-Bundle Pacing and Endocarditis How should we judge new ventricular ablation technologies, reassess survivors of apparently idiopathic ventricular fibrillation, and weigh the long-term consequences of pacing and infection-management decisions? In Issue 43 of EP Edge Journal Watch, Dr. Sharma examines ventricular arrhythmias, cardiac resynchronization, implanted-device safety, and infective endocarditis. Four featured discussions cover CLEAR-VT with its companion device analysis, long-term outcomes after idiopathic ventricular fibrillation, His-Alternative I, and the American Heart Association’s endocarditis scientific statement, including the POET trial. Shorter reviews address focal pulsed field ablation, arrhythmogenic cardiomyopathy, Brugada syndrome, pacing-induced ventricular dysfunction, device-related infection risk, and cardiovascular nutrition. The episode is designed for cardiac electrophysiologists, cardiologists, fellows, and allied professionals seeking critical appraisal and practical clinical interpretation. Articles are listed below in newsletter order. Dasa: CLEAR-VT and Dual-Energy Lattice-Tip Ablation of Ventricular Arrhythmias. Featured discussion. Early US experience demonstrates procedural feasibility in a selected, challenging population.

Publisher

EP Edge Journal Watch: Cardiac Electrophysiology Research

Link

share.transistor.fm/s/720aa437

Published

November 2, 2026

Duration

28 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Niraj Sharma MD FACC FHRS: Cardiac Electrophysiology & Cardiology

EE

EP Edge Journal Watch: Cardiac Electrophysiology Research

@epedgejournalwatchcardiacele

#vtablation #idiopathicvf #bundlepacing #lifesciences #medicine

The Nile